World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
57
Citations
10272
World Ranking
4385
National Ranking
1987

Overview

Patricia K. Sonsalla is affiliated with Rutgers, The State University of New Jersey in the United States. This association situates them within an established academic institution known for its research contributions across multiple disciplines.

Their recent scholarly output does not currently include any listed papers, so specific research topics or contributions from recent work cannot be detailed.

There are no frequent co-authors recorded for this scientist, which suggests either independent research or collaboration not extensively documented in the current data set.

No frequent publication venues are noted, meaning there is no data indicating a pattern of publication in specific journals or conferences at this time.

Similarly, there is no recorded information on book publications or publishers related to Sonsalla, so contributions in book form are not available for analysis.

Their main fields of study and subfields of study have not been specified, leaving the precise disciplinary focus unclear from the data provided.

No explicit topics of work are documented, which would otherwise help clarify areas of research interest or thematic focus.

There are also no awards listed for Patricia K. Sonsalla that might highlight recognitions or honors received during their career.

Best Publications

  • Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

    Jiang-Fan Chen;Kui Xu;Jacobus P. Petzer;Roland Staal

  • Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity

    Patricia K. Sonsalla;William J. Nicklas;Richard E. Heikkila

  • Midbrain Dopaminergic Cell Loss in Parkinson's Disease and MPTP‐Induced Parkinsonism: Sparing of Calbindin‐D25k—Containing Cells

    Dwight C. German;Kebreten F. Manaye;Patricia K. Sonsalla;Barbara A. Brooks

  • Role of dopamine in the neurotoxic effects of methamphetamine.

    C J Schmidt;J K Ritter;P K Sonsalla;G R Hanson

  • Animal models of Parkinson's disease progression.

    Gloria E. Meredith;Patricia K. Sonsalla;Marie-Francoise Chesselet

  • The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice.

    Patricia K. Sonsalla;Richard E. Heikkila

  • Adenosine A2A receptors and brain injury: Broad spectrum of neuroprotection, multifaceted actions and “fine tuning” modulation

    Jiang Fan Chen;Patricia K. Sonsalla;Felicita Pedata;Alessia Melani

  • Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice.

    P K Sonsalla;D E Riordan;R E Heikkila

  • Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.

    Unknown

  • Calbindin-D28K-containing neurons in animal models of neurodegeneration: possible protection from excitotoxicity

    A. Iacopino;S. Christakos;D. German;P.K. Sonsalla

  • Treatment of mice with methamphetamine produces cell loss in the substantia nigra

    Patricia K Sonsalla;Nina D Jochnowitz;Gail D Zeevalk;Jo A Oostveen

  • Enhanced phosphatase activity attenuates α-synucleinopathy in a mouse model.

    Kang Woo Lee;Walter Chen;Eunsung Junn;Joo Young Im

  • Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.

    P K Sonsalla;J W Gibb;G R Hanson

  • Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.

    Richard E. Heikkila;Beth-Anne Sieber;Lawrence Manzino;Patricia K. Sonsalla

  • The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.

    Dwight C. German;Eric L. Nelson;Chang Lin Liang;Samuel G. Speciale

  • Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.

    A Giovanni;B A Sieber;R E Heikkila;P K Sonsalla

  • Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment

    Martin R. Gluck;Lily Y. Moy;Elizabeth Jayatilleke;Kelly A. Hogan

  • MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats.

    Patricia K. Sonsalla;Gail D. Zeevalk;Lawrence Manzino;Andrew Giovanni

  • Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice

    A Giovanni;B A Sieber;R E Heikkila;P K Sonsalla

  • Midbrain Dopaminergic Neurons in the Mouse that Contain Calbindin-D28kExhibit Reduced Vulnerability to MPTP-induced Neurodegeneration

    Chang Lin Liang;Christopher M. Sinton;Patricia K. Sonsalla;Dwight C. German

  • Long-term duodenal infusion of levodopa for motor fluctuations in parkinsonism.

    J. I. Sage;S. Trooskin;P. K. Sonsalla;R. Heikkila

  • Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism

    P. K. Sonsalla;D. S. Albers;G. D. Zeevalk

Frequent Co-Authors

Kebreten F. Manaye
Kebreten F. Manaye Howard University
Dwight C. German
Dwight C. German The University of Texas Southwestern Medical Center
M. Maral Mouradian
M. Maral Mouradian Rutgers, The State University of New Jersey
Alexandre de Mendonça
Alexandre de Mendonça University of Lisbon
Luísa V. Lopes
Luísa V. Lopes University of Lisbon
Jacqueline N. Crawley
Jacqueline N. Crawley University of California, Davis
Eliezer Masliah
Eliezer Masliah National Institutes of Health
Edward D. Hall
Edward D. Hall University of Kentucky
Robert H. Edwards
Robert H. Edwards University of California, San Francisco
Marie-Françoise Chesselet
Marie-Françoise Chesselet University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience opens doors to a variety of related online degrees and specialized career paths. For those interested in advocating for mental health or working in clinical settings, the most affordable online msw programs offer a direct route into social work and counseling roles. These programs can be a cost-effective way to expand your expertise in brain and behavior sciences.

If your goals include working with individuals diagnosed with autism or behavioral disorders, consider an accelerated bcba program online. These programs prepare graduates for board certification in behavior analysis, opening up specialized therapeutic careers.

For those seeking quick advancement, options like the 1 year online master's in social work provide an intensive track to leadership positions in the mental health field. Meanwhile, a solid foundation in psychology can be built through an accelerated psychology bachelor's degree online, which complements neuroscience study with insights into cognition and behavior.

Blending neuroscience with these flexible online degrees enhances your qualifications and broadens career opportunities in healthcare, research, and therapy.

Best Scientists Citing Patricia K. Sonsalla